Combined Dry Eye Treatment Protocol
For moderate-to-severe chronic dry eye, single-modality treatment rarely produces lasting results. Dr. Y. Shira Kresch uses a combined treatment protocol that integrates Intense Pulsed Light (IPL), Radiofrequency (RF), Low-Level Light Therapy (LLLT), manual gland expression, and adjunctive medical therapy — each addressing a different aspect of the underlying disease. This page explains how the combined protocol works, why it consistently outperforms single-modality treatment, and what to expect from the program at our Southfield, MI clinic.
Most patients arrive at our practice having tried one or two approaches without success: artificial tears, warm compresses, maybe a prescription eye drop. Sometimes a single in-office treatment elsewhere. When those approaches fail, it is usually not because the treatments themselves are ineffective — it is because dry eye disease is multi-mechanism, and treating one mechanism while ignoring the others leaves most of the disease unaddressed.
The combined protocol changes that. By addressing the vascular, mechanical, cellular, and inflammatory components of dry eye disease simultaneously, the protocol produces results that no individual therapy can match.
Why Combined Treatment Outperforms Single-Modality Treatment
According to the TFOS DEWS II Management and Therapy Report, dry eye disease is rarely a single problem. In moderate-to-severe cases, multiple disease mechanisms are typically active at the same time:
- Inflammatory blood vessels at the eyelid margin contribute to chronic gland inflammation
- Hardened oils physically block Meibomian gland flow
- Demodex mite overpopulation drives chronic eyelid inflammation
- Reduced cellular energy impairs gland recovery and tissue healing
- Tear film inflammation damages the ocular surface and perpetuates the disease cycle
- Inadequate tear production compounds the disease in many patients
No single in-office treatment addresses all of these. IPL targets vascular and inflammatory mechanisms but does not melt obstructions as effectively as RF. RF physically clears blockages but does not address vascular inflammation. LLLT stimulates cellular healing but is gentler and works best in combination with other modalities.
The combined protocol layers these therapies so each one handles the mechanism it does best — and the cumulative effect is significantly greater than any one approach alone.
The Components of the Combined Protocol
1. Comprehensive Diagnostic Evaluation
Every combined protocol starts with a thorough dry eye evaluation. The evaluation is not optional — without precise diagnostic data (meibography, tear osmolarity, breakup time, ocular surface staining, lid margin assessment), there is no way to know which modalities to apply, in what sequence, or at what intensity for an individual patient.
2. Intense Pulsed Light (IPL)
IPL is the most-cited in-office dry eye treatment in peer-reviewed literature. It delivers calibrated pulses of broad-spectrum light to the skin around the eyes, targeting the abnormal inflammatory blood vessels that drive Meibomian gland dysfunction in many patients. IPL also has significant effects on Demodex populations and on the inflammatory cascade more broadly.
IPL is particularly valuable for patients with ocular rosacea, Demodex blepharitis, and chronic inflammatory MGD.
3. Radiofrequency Therapy (RF)
RF uses controlled, temperature-monitored energy to heat the eyelid tissue and surrounding skin to the therapeutic temperature needed to melt hardened, waxy Meibomian gland obstructions. Unlike at-home warm compresses, RF reaches and maintains the temperature required to actually clear gland blockages.
RF is the mechanical clearing step of the protocol — after IPL has addressed the vascular and inflammatory contributors, RF clears the physical obstructions that have built up over time.
4. Low-Level Light Therapy (LLLT)
LLLT uses specific wavelengths of red and near-infrared light to stimulate cellular activity in the Meibomian glands and surrounding tissue. It increases mitochondrial energy production, local circulation, and tissue healing — supporting recovery between active treatment sessions.
LLLT is the cellular healing layer of the protocol. It is also one of the gentlest treatments available and can often be performed in patients who cannot tolerate IPL for any reason.
5. Manual Meibomian Gland Expression
After the energy-based treatments have warmed the tissue and reduced inflammation, Dr. Kresch performs manual gland expression — physically pressing the eyelids to release the now-liquefied oil from the glands. This is significantly more effective when combined with prior IPL/RF than when performed in isolation.
6. Adjunctive Medical Therapy
Combined protocols typically also include prescription eye drops (anti-inflammatory or immunomodulator), omega-3 supplementation, lid hygiene routines, and lifestyle adjustments. The in-office treatments are the active recovery phase; medical and lifestyle therapy maintains and extends the results.
How the Protocol Is Sequenced
The standard combined protocol involves a series of treatments over several weeks:
- Week 0 — Comprehensive evaluation, diagnosis, treatment plan, baseline imaging
- Week 2-3 — First session: IPL + RF + LLLT + manual expression
- Week 5-6 — Second session: IPL + RF + LLLT + manual expression
- Week 8-9 — Third session: IPL + RF + LLLT + manual expression
- Week 12 — Fourth session (if indicated based on response)
- Month 6 and beyond — Maintenance treatments every 6-12 months
Adjunctive medical therapy continues throughout, and lifestyle adjustments become permanent habits.
Who Is a Candidate for the Combined Protocol?
The combined protocol is appropriate for patients with:
- Moderate-to-severe Meibomian Gland Dysfunction
- Chronic dry eye not responsive to standard treatment
- Ocular rosacea with associated MGD
- Demodex blepharitis with concurrent MGD
- Post-LASIK dry eye with significant evaporative component
- Patients with significant gland atrophy who want to preserve remaining function
The protocol is not appropriate for every patient — purely aqueous-deficient dry eye, severely advanced gland atrophy, or specific autoimmune presentations may require different approaches. The diagnostic evaluation determines candidacy.
Why Patients Travel to Our Southfield Clinic for the Combined Protocol
Most general optometry practices do not offer combined protocols because they require expertise across multiple treatment modalities and the equipment for each. Our Southfield clinic is built around comprehensive dry eye care, with all three energy-based modalities (IPL, RF, LLLT) available in-house — along with the diagnostic imaging needed to apply them effectively.
Our combined dry eye protocol layers the therapies that work best together for your case. When the ocular surface needs protection beyond in-office treatment, a specialty lens can be part of the plan — and our affiliated practice Michigan Contact Lens fits scleral lenses for severe dry eye. Dr. Kresch treats patients at both practices, so every part of your care stays coordinated.
Frequently Asked Questions
Q: How long does the combined protocol take? The initial active treatment series typically runs 8 to 12 weeks (3 to 4 sessions). After that, most patients move into maintenance care with treatments every 6 to 12 months.
Q: How long until I notice results? Many patients notice symptom improvement after the first or second session. Cumulative benefit builds through the series, with the full effect typically apparent by the end of the initial treatment series.
Q: Is the protocol the same for every patient? No. The protocol is customized based on diagnostic findings. Some patients need more IPL emphasis, others need more RF emphasis, and the sequence may vary based on individual response. The framework is consistent; the application is individualized.
Q: Can I do just one of the treatments instead of the combined protocol? You can, but the results are usually less complete. Single-modality treatment is appropriate for some specific cases (mild MGD, early disease, contraindications to specific modalities). For moderate-to-severe cases, the combined protocol consistently outperforms any single approach.
Q: Does insurance cover the combined protocol? The diagnostic evaluation is typically covered by medical insurance. The in-office treatments (IPL, RF, LLLT) are generally considered elective and are not covered. We discuss cost transparently before treatment begins and provide receipts you can submit to your insurance.
Q: Will I need treatments forever? Dry eye disease (especially MGD-driven dry eye) is chronic and progressive. Maintenance treatments help preserve the gains from the initial protocol and prevent disease progression. Most patients move from intensive treatment to maintenance after the first 6 to 12 months.
Q: What if the combined protocol does not work for me? A small percentage of patients have disease that does not respond fully to in-office treatments — particularly patients with severe gland atrophy or significant autoimmune components. In those cases, scleral lenses are often the next step and can provide dramatic symptom relief even when other approaches have not worked.